Literature DB >> 27554301

Effects of disinfectants against norovirus virus-like particles predict norovirus inactivation.

Jun Sato1, Motohiro Miki2, Hiromi Kubota3, Jun Hitomi1, Hajime Tokuda1, Reiko Todaka-Takai2, Kazuhiko Katayama4.   

Abstract

Human noroviruses (NoVs) are a major cause of epidemic and sporadic acute gastroenteritis worldwide. Public and personal hygiene is one of the most important countermeasures for preventing spread of NoV infection. However, no a practicable cell culture system for NoV had been developed, initial tests of the virucidal effectiveness of anti-NoV disinfectants and sanitizers have been performed using surrogate viruses. In this study, NoV virus-like particles (VLPs) were used as a new surrogate for NoVs and a method for evaluating NoV inactivation using them developed. This method is based on morphological changes in VLPs after treatment with sodium hypochlorite. VLP specimens were found to become deformed and degraded in a concentration-dependent manner. Based on these results, the effects of sodium hypochlorite on VLPs were classified into four phases according to morphological changes and number of particles. Using the criteria thus established, the efficacy of ethanol, carbonates and alkali solutions against VLPs was evaluated. Deformation and aggregation of VLPs were observed after treatment with these disinfectants under specific conditions. To determine the degradation mechanism(s), VLPs were examined by SDS-PAGE and immunoblotting after treatment with sodium hypochlorite and ethanol. The band corresponding to the major capsid protein, VP1, was not detected after treatment with sodium hypochlorite at concentrations greater than 500 ppm, but remained after treatment with ethanol. These results suggest that VLPs have excellent potential as a surrogate marker for NoVs and can be used in initial virucidal effectiveness tests to determine the mechanism(s) of chemical agents on NoVs.
© 2016 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  disinfectants; norovirus; virus-like particles

Mesh:

Substances:

Year:  2016        PMID: 27554301     DOI: 10.1111/1348-0421.12435

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Immune-Focusing Properties of Virus-like Particles Improve Protective IgA Responses.

Authors:  Taishi Onodera; Kana Hashi; Rajni Kant Shukla; Motohiro Miki; Reiko Takai-Todaka; Akira Fujimoto; Masayuki Kuraoka; Tatsuya Miyoshi; Kazuo Kobayashi; Hideki Hasegawa; Manabu Ato; Garnett Kelsoe; Kazuhiko Katayama; Yoshimasa Takahashi
Journal:  J Immunol       Date:  2019-11-08       Impact factor: 5.422

2.  Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids.

Authors:  Kosuke Murakami; Victoria R Tenge; Umesh C Karandikar; Shih-Ching Lin; Sasirekha Ramani; Khalil Ettayebi; Sue E Crawford; Xi-Lei Zeng; Frederick H Neill; B Vijayalakshmi Ayyar; Kazuhiko Katayama; David Y Graham; Erhard Bieberich; Robert L Atmar; Mary K Estes
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-02       Impact factor: 11.205

Review 3.  Bactericidal and virucidal activity of ethanol and povidone-iodine.

Authors:  Andreas Sauerbrei
Journal:  Microbiologyopen       Date:  2020-06-22       Impact factor: 3.139

4.  Illuminating Human Norovirus: A Perspective on Disinfection of Water and Surfaces Using UVC, Norovirus Model Organisms, and Radiation Safety Considerations.

Authors:  Richard M Mariita; James H Davis; Rajul V Randive
Journal:  Pathogens       Date:  2022-02-08

5.  Experimental Adaptation of Murine Norovirus to Calcium Hydroxide.

Authors:  Wakana Oishi; Mikiko Sato; Kengo Kubota; Ryoka Ishiyama; Reiko Takai-Todaka; Kei Haga; Kazuhiko Katayama; Daisuke Sano
Journal:  Front Microbiol       Date:  2022-03-31       Impact factor: 5.640

6.  Effect of natural ageing and heat treatments on GII.4 norovirus binding to Histo-Blood Group Antigens.

Authors:  Maëlle Robin; Manon Chassaing; Julie Loutreul; Alexis de Rougemont; Gaël Belliot; Didier Majou; Christophe Gantzer; Nicolas Boudaud
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.